PCOVERY ApS - CVR: 32086926

2017, DKK

11.06.2018

Bruttoresultat

0

Primær drift

-5.722'

Årets resultat

-5.671'

Aktiver

1.597'

Kortfristede aktiver

1.597'

Egenkapital

-4.944'

Afkastningsgrad

-358 %

Soliditetsgrad

-309 %

Likviditetsgrad

24 %

Resultat

11.06.2018

Årsrapport	2017 11.06.2018	2016 07.06.2017	2015 26.05.2016
Nettoomsætning	0	79.252
Bruttoresultat	0	79.252	0
Resultat af primær drift	-5.722.379	-17.446.287	0
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0
Finansielle indtægter	211.150	1.357.851	0
Finansieringsomkostninger	-159.582	-213.360	-156.050
Andre finansielle omkostninger	0	0	0
Resultat før skat	-5.670.811	-16.301.796	-18.812.590
Resultat	-5.670.811	-12.911.665	-14.801.476
Forslag til udbytte	0	0	0

Aktiver

11.06.2018

Årsrapport	2017 11.06.2018	2016 07.06.2017	2015 26.05.2016
Kortfristede varebeholdninger	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	1.597.367	3.720.525	4.398.745
Likvider	0	4.553.496	7.998.382
Kortfristede aktiver	1.597.367	8.274.021	12.397.127
Immaterielle aktiver og goodwill	0	0	0
Finansielle anlægsaktiver	0	0	111.240
Materielle aktiver	0	197.206	366.581
Langfristede aktiver	0	197.206	477.821
Aktiver	1.597.367	8.471.227	12.874.948

Aktiver

11.06.2018

Passiver

11.06.2018

Årsrapport	2017 11.06.2018	2016 07.06.2017	2015 26.05.2016
Forslag til udbytte	0	0	0
Egenkapital	-4.943.630	727.181	2.605.756
Hensatte forpligtelser	0	0	0
Langfristet gæld til banker	0	0	0
Anden langfristet gæld	0	0	0
Leverandører af varer og tjenesteydelser	110.019	642.780	1.164.602
Kortfristede forpligtelser	6.540.997	7.744.046	4.889.064
Gældsforpligtelser	6.540.997	0	10.269.192
Forpligtelser	6.540.997	0	10.269.192
Passiver	1.597.367	8.471.227	12.874.948

Passiver

11.06.2018

Nøgletal

11.06.2018

Årsrapport	2017 11.06.2018	2016 07.06.2017	2015 26.05.2016
Afkastningsgrad	-358,2 %	-205,9 %	Na.
Dækningsgrad	Na.	100,0 %	Na.
Resultatgrad	Na.	-16.291,9 %	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.
Egenkapitals-forretning	114,7 %	-1.775,6 %	-568,0 %
Payout-ratio	Na.	Na.	Na.
Gældsdæknings-nøgletal	-3.585,9 %	-8.176,9 %	Na.
Soliditestgrad	-309,5 %	8,6 %	20,2 %
Likviditetsgrad	24,4 %	106,8 %	253,6 %

Resultat

11.06.2018

Gæld

11.06.2018

Årsrapport

11.06.2018

Nyeste:01.01.2017- 31.12.2017(offentliggjort: 11.06.2018)

Information om virksomhedens regnskabsklasse:The annual report of PCOVERY ApS under frivillig likvidation for 2017 has been prepared in accordance with the provisions in the Danish Financial Statements Act applying to reporting class B entities and elective choice of certain provisions applying to reporting class C entities.

Beretning

11.06.2018

Dato for ledelsens godkendelse af årsrapporten:2018-05-31

Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen:Going concern The Company's 2017 operations until liquidation has been financed through cash and cash equivalents and tax credits arising from research and development activities conducted during 2016. The Company has a convertible loan at one of the shareholders. The Company døs not have sufficient cash to repay the loan in full. According to funding agreement, the shareholder may not require the Company to repay the remaining loan and accrued interest if, as a result of such repayment, the Company is reasonable likely to become insolvent. On this basis, the Liquidator assesses that the Company has sufficient funds to meet operational requirements through 2018. Reference is made to note 2 for more details.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, I have discussed and approved the annual report of PCOVERY ApS under frivillig likvidation for the financial year 1 January - 31 December 2017.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's prior main activity has been research and development. The Company has focused on developing new drugs for treatment of invasive fungal infections. Pcovery aimed to develop a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. At the ordinary general meeting on 31 May 2017, it was decided to dissolve the Company under the rules of solvent liquidation of the Danish Companies Act. The Company remains under liquidation and there has been limited activity during the current year. During 2017, Liquidator has focused on winding up the Company, i. e. to advertise for creditors, settle all liquidator approved claims and to sell off the Company's IP portfolio. For cost saving reasons and as per shareholder instructions, only limited resources have been allocated to identify potential buyers, considering the very early stage of the research conducted and that the project has been given up upon. As a result, only one bid was received and eventually accepted. Liquidator expects that the Company can be finally liquidated in 2018 as the only outstanding formality is for the Danish IRS to confirm that no taxes are due.